103 related articles for article (PubMed ID: 22869559)
1. Isolation and quantitation of topoisomerase complexes accumulated on Escherichia coli chromosomal DNA.
Aedo S; Tse-Dinh YC
Antimicrob Agents Chemother; 2012 Nov; 56(11):5458-64. PubMed ID: 22869559
[TBL] [Abstract][Full Text] [Related]
2. Selective targeting of topoisomerase IV and DNA gyrase in Staphylococcus aureus: different patterns of quinolone-induced inhibition of DNA synthesis.
Fournier B; Zhao X; Lu T; Drlica K; Hooper DC
Antimicrob Agents Chemother; 2000 Aug; 44(8):2160-5. PubMed ID: 10898691
[TBL] [Abstract][Full Text] [Related]
3. Interactions between Gepotidacin and
Oviatt AA; Gibson EG; Huang J; Mattern K; Neuman KC; Chan PF; Osheroff N
ACS Infect Dis; 2024 Apr; 10(4):1137-1151. PubMed ID: 38606465
[TBL] [Abstract][Full Text] [Related]
4. Role of the Water-Metal Ion Bridge in Quinolone Interactions with
Carter HE; Wildman B; Schwanz HA; Kerns RJ; Aldred KJ
Int J Mol Sci; 2023 Feb; 24(3):. PubMed ID: 36769202
[TBL] [Abstract][Full Text] [Related]
5. Breakage-reunion domain of Streptococcus pneumoniae topoisomerase IV: crystal structure of a gram-positive quinolone target.
Laponogov I; Veselkov DA; Sohi MK; Pan XS; Achari A; Yang C; Ferrara JD; Fisher LM; Sanderson MR
PLoS One; 2007 Mar; 2(3):e301. PubMed ID: 17375187
[TBL] [Abstract][Full Text] [Related]
6. A CcdB toxin-derived peptide acts as a broad-spectrum antibacterial therapeutic in infected mice.
Bhowmick J; Nag M; Ghosh P; Rajmani RS; Chatterjee R; Karmakar K; Chandra K; Chatterjee J; Chakravortty D; Varadarajan R
EMBO Rep; 2023 Jul; 24(7):e55338. PubMed ID: 37166011
[TBL] [Abstract][Full Text] [Related]
7. Metabolic engineering for L-glutamine overproduction by using DNA gyrase mutations in Escherichia coli.
Hayashi M; Tabata K
Appl Environ Microbiol; 2013 May; 79(9):3033-9. PubMed ID: 23455340
[TBL] [Abstract][Full Text] [Related]
8. Quinolones: action and resistance updated.
Drlica K; Hiasa H; Kerns R; Malik M; Mustaev A; Zhao X
Curr Top Med Chem; 2009; 9(11):981-98. PubMed ID: 19747119
[TBL] [Abstract][Full Text] [Related]
9. Escherichia coli Topoisomerase IV E Subunit and an Inhibitor Binding Mode Revealed by NMR Spectroscopy.
Li Y; Wong YL; Ng FM; Liu B; Wong YX; Poh ZY; Liu S; Then SW; Lee MY; Ng HQ; Huang Q; Hung AW; Cherian J; Hill J; Keller TH; Kang C
J Biol Chem; 2016 Aug; 291(34):17743-53. PubMed ID: 27365392
[TBL] [Abstract][Full Text] [Related]
10. Basis for the discrimination of supercoil handedness during DNA cleavage by human and bacterial type II topoisomerases.
Jian JY; McCarty KD; Byl JAW; Guengerich FP; Neuman KC; Osheroff N
Nucleic Acids Res; 2023 May; 51(8):3888-3902. PubMed ID: 36999602
[TBL] [Abstract][Full Text] [Related]
11. Covalent Complex of DNA and Bacterial Topoisomerase: Implications in Antibacterial Drug Development.
Tiwari PB; Chapagain PP; Seddek A; Annamalai T; Üren A; Tse-Dinh YC
ChemMedChem; 2020 Apr; 15(7):623-631. PubMed ID: 32043806
[TBL] [Abstract][Full Text] [Related]
12. The C-terminal domain of DNA gyrase A adopts a DNA-bending beta-pinwheel fold.
Corbett KD; Shultzaberger RK; Berger JM
Proc Natl Acad Sci U S A; 2004 May; 101(19):7293-8. PubMed ID: 15123801
[TBL] [Abstract][Full Text] [Related]
13. In front of and behind the replication fork: bacterial type IIA topoisomerases.
Sissi C; Palumbo M
Cell Mol Life Sci; 2010 Jun; 67(12):2001-24. PubMed ID: 20165898
[TBL] [Abstract][Full Text] [Related]
14. Highly sensitive mapping of
Morgan IL; McKie SJ; Kim R; Seol Y; Xu J; Harami G; Maxwell A; Neuman KC
bioRxiv; 2024 May; ():. PubMed ID: 38798569
[TBL] [Abstract][Full Text] [Related]
15. Hydrazyl hydroxycoumarins as new potential conquerors towards Pseudomonas aeruginosa.
Zhao JS; Ahmad N; Li S; Zhou CH
Bioorg Med Chem Lett; 2024 May; 103():129709. PubMed ID: 38494040
[TBL] [Abstract][Full Text] [Related]
16. Crystallization and initial crystallographic analysis of covalent DNA-cleavage complexes of Staphyloccocus aureus DNA gyrase with QPT-1, moxifloxacin and etoposide.
Srikannathasan V; Wohlkonig A; Shillings A; Singh O; Chan PF; Huang J; Gwynn MN; Fosberry AP; Homes P; Hibbs M; Theobald AJ; Spitzfaden C; Bax BD
Acta Crystallogr F Struct Biol Commun; 2015 Oct; 71(Pt 10):1242-6. PubMed ID: 26457513
[TBL] [Abstract][Full Text] [Related]
17. Benzothiazole DNA gyrase inhibitors and their conjugates with siderophore mimics: design, synthesis and evaluation.
Durcik M; Cruz CD; Scorciapino MA; Ilaš J; Tammela P; Ceccarelli M; Mašič LP; Tomašič T
RSC Adv; 2024 Jan; 14(5):2905-2917. PubMed ID: 38239435
[TBL] [Abstract][Full Text] [Related]
18. Interaction of silver atomic quantum clusters with living organisms: bactericidal effect of Ag
Neissa J; Pérez-Arnaiz C; Porto V; Busto N; Borrajo E; Leal JM; López-Quintela MA; García B; Dominguez F
Chem Sci; 2015 Dec; 6(12):6717-6724. PubMed ID: 29861921
[TBL] [Abstract][Full Text] [Related]
19. Fighting antibacterial drug resistance.
Supuran CT
Expert Opin Ther Pat; 2024 Jun; ():1-4. PubMed ID: 38866729
[No Abstract] [Full Text] [Related]
20. SbcCD-mediated processing of covalent gyrase-DNA complex in Escherichia coli.
Aedo S; Tse-Dinh YC
Antimicrob Agents Chemother; 2013 Oct; 57(10):5116-9. PubMed ID: 23917316
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
